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Identiボcation of DHXぶ as a cell 
cycle regulated nucleolar 
recruitment factor for CIZの
Urvi Thackerの┸ Tekle Pauzaiteの┸ James Tollittの┸ Maria Twardowskaの┸ Charlotte Harrisonは┸ 
Adam Dowleば┸ Dawn Coverleyは ┃ Nikki A┻ Copelandの*
CIPの┽interacting zinc ボnger protein の ゅCIZのょ is a nuclear matrix associated protein that facilitates a 
number of nuclear functions including initiation of DNA replication┸ epigenetic maintenance and 
associates with the inactive X┽chromosome┻ Here┸ to gain more insight into the protein networks that 
underpin this diverse functionality┸ molecular panning and mass spectrometry are used to identify 
protein interaction partners of CIZの┸ and CIZの replication domain ゅCIZの┽RDょ┻ STRING analysis of 
CIZの interaction partners identiボed は functional clusters┺ ribosomal subunits and nucleolar proteins 
including the DEAD box helicases┸ DHXぶ┸ DDXひ and DDXのぴ┻ DHXぶ shares common functions with 
CIZの┸ including interaction with XIST long┽non┽coding RNA┸ epigenetic maintenance and regulation 
of DNA replication┻ Functional characterisation of the CIZの┽DHXぶ complex showed that CIZの┽DHXぶ 
interact in vitro and dynamically colocalise within the nucleolus from early to mid S┽phase┻ CIZの┽DHXぶ 
nucleolar colocalisation is dependent upon RNA polymerase I activity and is abolished by depletion 
of DHXぶ┻ In addition┸ depletion of DHXぶ reduced cell cycle progression from Gの to S┽phase in mouse 
ボbroblasts┻ The data suggest that DHXぶ┽CIZの are required for eポcient cell cycle progression at the 
Gの【S transition and that nucleolar recruitment is integral to their mechanism of action┻
he precise duplication of the genome is a highly regulated process that ensures genomic stability. he forma-
tion of putative replication origins, origin licensing and initiation of DNA replication are highly orchestrated 
processes that are tightly regulated by sequential cyclin-CDK complexes and Dbf4 dependent kinase (DDK)1,2. 
DNA replication initiates at thousands of replication origins to facilitate eicient and expedient duplication of 
the  genome3,4. Temporospatial regulation of DNA replication is mediated by recruitment of cyclin dependent 
kinases to chromatin, a process that is mediated in part by Cip1 interacting zinc inger protein 1 (CIZ1)5. CIZ1 
promotes DNA replication in mammalian  cells6 and is part of an extraction-resistant compartment, or nuclear 
matrix, in the  nucleus7. CIZ1 interacts with pre-replication complex proteins  Cdc68, cell cycle regulators cyclin 
E, cyclin  A5 and the CDK inhibitor protein  p219 consistent with a role in cell cycle  regulation10.
CIZ1 can be divided into two functional domains. he N-terminal replication domain (CIZ1-RD, also termed 
CIZ1-N471 in earlier work) associates with cyclin A to promote initiation of DNA replication in vitro and the 
C-terminal anchor domain (CIZ1-AD) localises CIZ1 to the DNase-resistant nuclear matrix (Fig. 1A)5,7. CIZ1 
mediates recruitment of cyclin A to non-chromatin  structures5. CIZ1 DNA replication activity is mediated 
through cyclin A interactions as mutation of the Cy ii-motif (K/RXL, K321) prevented cyclin A binding and 
abolished CIZ1’s DNA replication  activity5. CDK-mediated phosphorylation of CIZ1 at multiple sites also regu-
lates cyclin interaction and CIZ1  activity8. CIZ1 promotes cyclin A recruitment and initiation of DNA replica-
tion in a hypophosphorylated state, while hyperphosphorylation abolishes CIZ1 DNA replication activity. his 
describes an autoregulatory feedback loop that may contribute to mechanisms that ensure replication occurs 
exactly once per cell  cycle8.
CIZ1 contributes several processes in addition to its role in cyclin recruitment to the nuclear matrix. CIZ1 
interacts with the inactive X-chromosome in female  cells11–13, is implicated in oestrogen receptor mediated 
transcriptional  regulation14. Mutation of the CIZ1 gene has been linked with varied diseases including cervical 
 dystonia15 and Alzheimer’s  disease16. Furthermore, CIZ1 overexpression or mis-splicing promotes tumour cell 
growth and targeted depletion of CIZ1 can reduce cellular proliferation or tumour  size10,17–23. In addition, CIZ1 
also displays tumour suppressor activity in CIZ1 ablated murine  models11,24. Both deletion and overexpression 
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Figure 1.  Identiication of CIZ1 interaction partners by MALDI MS/MS. (A) Schematic of murine CIZ1, 
showing translated exons (numbered), and those that encode the DNA replication domain encoded by CIZ1 
fragment RD (exons 2–9 and part of 10, shown in yellow and red box)5. he nuclear matrix anchor domain-
containing fragment (exon 10–17; grey box) is also  shown7. Reported CIZ1 spicing  events16,17,37,69 are shaded 
in dark grey in exons 4, 6, 8, and 14. (B) Four constructs were prepared for interaction screen: GST-ECIZ1, 
GST-ECIZ1 RD and DNA replication inactive GST-ECIZ1 N391. GST was used as a negative control. (C) 
MALDI-MS/MS and mascot database searching was used to identify interaction partners for CIZ1 (Table S1–4). 
STRING  analysis68 of ECIZ1 and ECIZ1-RD shared Interaction partners identify two clusters: RNA binding/
helicases (let) and ribosomal cluster (right). Functional interaction data is shown in key. (D) Common CIZ1-
DHX9 interaction partners were analysed by STRING analysis. he proteins identiied here share RNA binding/
helicase activities and ribosomal subunits as seen for CIZ1.
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of CIZ1 induces delocalisation of the non-coding X-inactive speciic transcript (XIST) RNA from the inactive 
X chromosome (Xi)12, suggesting that the levels of CIZ1 are important in the regulation of multiple processes.
To gain a more detailed understanding of CIZ1 function, we exploited characterised CIZ1 constructs that are 
capable of promoting initiation of DNA replication in vitro, to identify interaction partners in soluble extracts 
from HeLa cells. his approach identiied the DEAH box helicase DHX9 as the most signiicant interaction 
partner and the focus of this work is to functionally characterise their interaction. DHX9 is an RNA/DNA heli-
case associated with many aspects of nucleic acid metabolism including DNA  repair25, pre-mRNA  splicing26,27, 
RNA  interference28,  translation29 and DNA  replication25,30,31. Importantly, DHX9 shares common functions with 
CIZ1, including interaction with XIST long-non-coding  RNA11,12,32, epigenetic  regulation13,33 and regulation of 
DNA  replication5,8,34. DHX9 has been implicated in the DNA replication process through interaction with DNA 
polymerases α, δ, and ε25,  PCNA30, DNA topoisomerase  II31 and binding to active DNA replication  origins34. 
DHX9 associates with ilamentous actin present at the nucleolar  periphery35, which is the site for ribosomal 
DNA (rDNA)  replication36. Finally, DHX9 localises to the nucleolus during diferentiation in embryonic stem 
cells and regulates heterochromatin  formation33. he data presented here identify nuclear proteins that associate 
with CIZ1 that will enable further characterisation of CIZ1 function with emphasis on in vitro and in vivo char-
acterisation of the CIZ1-DHX9 complex. his work suggests DHX9 is required for Ciz1 nucleolar recruitment, 
and is required for eicient cell cycle progression at the G1/S transition.
Results
Identiボcation of CIZの interaction partners during S┽phase┻ he CIZ1 variant, ECIZ1 was cloned 
from an embryonic murine cDNA library and lacks the polyglutamine N-terminal sequences and is readily puri-
ied as recombinant ECIZ1 from E. coli6,7. hree functionally characterised murine ECIZ1-derived constructs 
were used to generate GST-tagged recombinant proteins (Fig. 1A,B) to proile interaction partners in soluble 
extracts from HeLa cells. his approach has been used previously to identify and analyse cyclin A-CDK25 and 
Cdc6  interactions8. Both  ECIZ15,6,8 and ECIZ1-derived ECIZ1-RD5,8 encode proteins that support initiation of 
DNA replication, while derived truncated fragment (ECIZ1-N3915,37) does not support DNA  replication5. All 
three baits, and GST alone, were incubated with nuclear extracts prepared from HeLa cells synchronised in early 
S-phase by double thymidine arrest. Recovered proteins were identiied ater on-bead trypsin digestion and liq-
uid chromatography tandem mass spectrometry (LC MS/MS) using Mascot database searching, and signiicant 
hits selected with conidence limits ≥ 99.5%, ≥ 2 peptides and best ion CI ≥ 99%. his yielded 53, 107, 2 and 1 
interactors for ECIZ1, ECIZ1-RD, ECIZ1-N391 and GST respectively (Table S1–4). Due to the low number of 
hits for control (GST) and DNA replication-inactive truncate N391, the analysis here focussed on DNA replica-
tion-competent ECIZ1 and ECIZ1-RD.
To provide greater insight into the biological signiicance of the CIZ1, CIZ1-RD dataset the interaction pro-
teins were analysed using  STRING38. his approach groups Ciz1-interacting proteins by functional relationships 
generating two clusters for both CIZ1 and CIZ1-RD (Figure S1,S2), ribosomal subunits (ECIZ1 False detec-
tion Rate (FDR) = 6e−48 Table S1, CIZ-RD FDR = 2.3e−82 Table S2) and DEAD box/ribonucleoprotein complexes 
(ECIZ1 FDR = 2.3e−51, CIZ1-RD FDR = 1.3e−40). Moreover, comparison of the interaction partner lists revealed 
that 42/53 ECIZ1 interaction partners were common to CIZ1-RD, with 9/10 present in both CIZ1 and CIZ-RD 
interaction partners (Table 1; Table S5; Fig. 1C). Signiicantly, only CIZ1 constructs that promote cell cycle pro-
gression (ECIZ1 and ECIZ1-RD), but not inactive CIZ1-N391 construct, were able to interact with these com-
plexes. CIZ1 has been shown to regulate cell cycle  progression5,8 and regulate localisation of  XIST11,12. herefore, it 
is striking that DDX5, DDX17 and DHX9 were identiied in the top 10 hits for both CIZ1 and CIZ1-RD (Table 1) 
are XIST interaction  partners32 and that DHX9 has also been reported to regulate cell cycle  progression34.
DHX9 (also known as RNA helicase A and NDH II, Uniprot number: Q08211) was the top hit for both CIZ1 
and CIZ1-RD. DHX9 is an RNA and DNA helicase that is proposed to function in several processes, includ-
ing activation of DNA replication  origins30, translational  eiciency35, RNA  interference36, viral  infection37 and 
interacts with XIST  RNA11,12. Of the known DHX9 interactor proteins in  Biogrid38, 21/239 are also identiied 
in our ECIZ1 or CIZ1-RD interactors. Analysis of CIZ1-DHX9 interaction partners in  STRING38 returned GO 
Table 1.  he top 10 interaction partners by conidence limits for CIZ1 and CIZ1-RD. Proteins highlighted in 
bold were found to interact with both CIZ1 and CIZ1-RD.
Rank ECIZ1 interactors Total on score
CIZ1-RD 
interactors Total on score
1 DHX9 579 DHX9 1514
2 Hist1h1e 517 ANXA2 967
3 ANXA2 376 DDX17 669
4 RPL15 344 RPL6 625
5 DDX17 337 DDX5 537
6 DDX5 257 DDX21 496
7 RPS10 230 RPS10 457
8 RPS3a 206 RPL15 454
9 RPS8 195 GNB2L1 447
10 CBR1 181 NPM1 437
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terms ribosome biogenesis and RNA metabolism with highest signiicance functions of the CIZ1 interactors 
(Fig. 1D; Table S6).
CIZの and DHXぶ form a stable complex in vitro┻ To validate the CIZ1-DHX9 interaction, GST-ECIZ1 
and derived fragments (Fig. 2A) were incubated with S-phase HeLa nuclear extracts and bound proteins ana-
lysed by western blot. Consistent with mass spectrometry results both ECIZ1 and CIZ1-RD recovered DHX9 
(Fig. 2B, Figure S3) while N391 did not, highlighting a dependence on the 80 amino-acid sequence previously 
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Figure 2.  CIZ1 directly associates with DHX9 in vitro. (A) Schematic representation of four constructs for 
interaction screen: GST-ECIZ1, GST-ECIZ1-RD, GST-ECIZ1 N391 and GST was used as a negative control. 
(B) Products of GST-CIZ1 interaction assay showing DHX9 detected by western blot. Upper panel shows 
load proteins, lower panel recovered DHX9. (C) Immunoprecipitation (IP) reactions from S-phase HeLa 
nuclear extracts. Pre-immune IgG controls and anti-CIZ1 N471 antibody and RNAse A/DNase I were added 
as indicated. Upper panel shows CIZ1 and DHX9 load. Lower panel detected DHX9 ater IP. (D) Synchronised 
G1, G1/S and Mid S-phase HeLa S3 extracts were prepared and synchronisation conirmed by cyclin E and A 
 abundance5. (E) CIZ1-DHX9 interaction in mid G1, Late G1 or S-phase extracts using the indicated constructs. 
Let panel, GST control and RD; right panel, CIZ1-RD ± DNase or RNase added to binding reactions as 
indicated. (F) Quantitative reverse transcriptase PCR (qRT-PCR) analysis of DHX9 transcripts, 24 h ater 
transfection of mouse NIH3T3 cells with control siRNA and DHX9 siRNA. Transcript levels for DHX9 are 
shown relative to GAPDH. G) Western blots showing efect of control siRNA and DHX9 siRNA on DHX9, CIZ1 
and actin. Full-length blots are found in supplemental material. (H) Mouse NIH3T3 cells were synchronised in 
G0, siRNA treated and cell cycle re-entry monitored by EdU incorporation. he percentage of cells in S-phase 
for control (blue) and DHX9 depleted cells (red) are shown. Statistical signiicance was determined by ANOVA 
plot with Tukey post hoc analysis for time points are shown. **indicates P < 0.01 and ***indicates P < 0.001.
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shown to be required for CIZ1 DNA replication  activity5. Next to assess if CIZ1 and DHX9 associate in vivo, 
immunoprecipitation assays were performed using matched IgG from pre-immune rabbits and CIZ1 speciic 
antibodies (Fig. 2C). his demonstrated that endogenous CIZ1 and DHX9 associate in vivo and this is inde-
pendent of DNA and RNA. To assess whether there was a cell-cycle dependence to this interaction, nuclear 
extracts were isolated from HeLa cells synchronised in G1 phase, early or mid S-phase. Synchronisation was 
conirmed by expression of cyclin E and A as cyclin E peaks in late G1 phase, then decreases as cyclin A accu-
mulates during S-phase  entry5 (Fig. 2D, Figure S3). DHX9 was expressed at similar levels in all three extracts 
and was successfully retrieved by GST-CIZ1, and GST-CIZ1-RD, indicating a stable interaction mediated via 
the N-terminal domain of CIZ1 (Fig. 2E, let panel; Figure S3). As CIZ1 and DHX9 can interact with nucleic 
 acids39–41, binding assays were performed with DNase 1 or RNase A. In this context, CIZ1 and CIZ1-RD were 
able to recover DHX9 from nuclear extracts (Fig. 2E, right panel), although there was reduced recovery with 
DNase 1 in mid G1 extracts that may be associated with a reduced ainity in G1 phase that increases in S-phase 
(Fig. 2E, Figure S3). hese data show that CIZ1-DHX9 interact throughout G1 and S-phase, and suggest that this 
interaction is not dependent on nucleic acids.
To assess whether DHX9 has a role in regulation of the cell cycle, mouse ibroblasts were synchronised in G0 
by contact inhibition and serum  starvation5,6,8,37,42 and transfected with control siRNA or anti-DHX9 siRNAs 
followed by release into the cell cycle. his resulted in a reduction in both DHX9 transcript (Fig. 2F) and protein 
levels (Fig. 2G, Figure S3). here is also a reduction in CIZ1 levels that may be due reduced cell cycle progression, 
as CIZ1 levels accumulate from the G1/S  transition8. In addition, we cannot exclude that possibility that DHX9 
increases CIZ1 stability preventing its degradation in this phase of the cell cycle. To determine if DHX9 deple-
tion afects cell cycle re-entry was monitored during the following 24 h by EdU incorporation to determine the 
proportion of cells in S-phase. Depletion of DHX9 was associated with a signiicant decrease relative to controls 
at 22 and 24 h (Fig. 2H). hese observations parallel similar analysis of the efect of depletion of CIZ1, which 
also resulted in restrained entry to S-phase, via a mechanism that interferes with timely pre-initiation complex 
(pre-IC)  conversion5,6. he reduction in CIZ1 protein levels, caused by depletion of DHX9, may be associated 
with a reduction in S-phase cells (Fig. 2H), as CIZ1 expression increases during G1 phase and is maximally 
expressed in S-phase8. Alternatively, this could be more directly related to suppression of DHX9-containing 
protein complexes. Nevertheless, the data presented here are consistent with other analyses that demonstrated 
that DHX9 is required for eicient cell cycle progression and initiation of DNA  replication34.
DHXぶ┽CIZの dynamically co┽localise in the nucleolus in early S┽phase┻ DHX9 localises to the 
nucleolus in mouse  ibroblasts43, but CIZ1 is not known to accumulate at the nucleolus. However, nucleolar 
localisation is a common feature of ECIZ1 binding proteins as identiied by STRING analysis with 19/53 for 
ECIZ1 (FDR = 3.5e−12) and 36/107 for CIZ1-RD (FDR = 7.26e−23) (Table S1, S2). Immunoluorescence revealed 
that CIZ1 and DHX9 colocalised in regions with low DAPI luorescence, consistent with the nucleolus (Fig. 3A, 
Figure S4S4/Supplementary video 1 and Figure S5A). Next, the nucleolar markers nucleophosmin (B23) and 
upstream binding factor (UBF) were used to determine if DHX9 and CIZ1 were localised within the nucleolus. 
Immunoluorescence confocal microscopy was used with nucleolar markers nucleophosmin (B23) in combina-
tion with DHX9, and upstream binding factor (UBF) in combination with CIZ1 (Fig. 3A). he data indicate 
that CIZ1 is localised to the nucleolus in a subset of cells, where it was found to be colocalised with DHX9 or 
UBF, suggesting that CIZ1 is present in both the ibrillar center (FC) and granular component (GC). he data 
presented are consistent with a nucleolar function for CIZ1 and DHX9.
CIZ1 is associated with the inactive X-chromosome in normal female cells, visible as a condensed hetero-
chromatic region within the  nucleus11–13 typically proximal to the nucleolus or nuclear envelope. In addition, 
in primary cells Ciz1 is transiently associated with perinucleolar  regions13. To conirm that the CIZ1 aggregates 
shown here are independent of the inactive X-chromosome, the hTERT-immortalized human male foreskin 
ibroblast BJ cell line was used. CIZ1-DHX9 was visualised in the nucleolus, yielding consistent results to HeLa 
cells (Fig. 3B). In BJ cells, CIZ1-UBF and DHX9-nucleophosmin show nucleolar colocalisation (Fig. 3B). hus, 
nucleolar CIZ1-DHX9 is found in both male and female human cell lines. To further support the nucleolar 
localisation of CIZ1 and DHX9, nuclei were puriied by sequential sucrose step fractionation and  sonication44. 
Nucleoli were puriied from HeLa cells and this showed that DHX9 and CIZ1 were present in the nuclear and 
nucleolar fractions. DHX9 was not detected in the nucleosolic fraction ater sonication, whereas CIZ1 was 
detected consistent with the release of non-nucleolar CIZ1 (Fig. 3C, D, and Figure S6).
To investigate whether nucleolar localisation of CIZ1 and DHX9 are cell cycle regulated, HeLa cells were 
synchronised by two methods: mitotic release using nocodazole (Figure S4), and double thymidine arrest and 
release (Fig. 3). Both synchronisation approaches revealed that CIZ1-DHX9 were enriched at nucleoli in early to 
mid S-phase (Fig. 3E; Figure S5A). Representative images at two-hour intervals ater release from the thymidine 
block are shown (Fig. 3F), and cell cycle progression conirmed by low cytometry (Fig. 3G) and S-phase labelling 
with BrdU (Fig. 3H). Quantiication of CIZ1-DHX9 nucleolar localisation through S-phase (Fig. 3I) conirmed 
that CIZ1-DHX9 peaks 4 h ater release from thymidine block, which reduced sharply as cells progressed into 
late S-phase (6–8 h ater release; Fig. 3I; Figure S5B). Importantly, similar results were found for a population of 
HeLa cells synchronised arrested in mitosis using nocodazole (Figure S7), suggesting this response is not due 
to the drug induced cell cycle synchronisation. his analysis of the temporal dynamics of CIZ1-DHX9 colo-
calisation points to an S-phase speciic function and suggests that CIZ1 dynamically associates with nucleoli in 
human cell lines.
CIZの nucleolar localisation is DHXぶ dependent┻ he interaction between CIZ1 and DHX9 in vitro, 
and their nucleolar colocalisation during early S-phase suggests a common function. To determine whether 
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CIZ1 nucleolar localisation is dependent on DHX9, DHX9 nucleolar localisation was disrupted by addition 
of nanomolar quantities of actinomycin D that inhibits RNA polymerase I and abolishes DHX9 nucleolar 
 localisation43. HeLa cells were treated with actinomycin D, and the distribution of CIZ1 and DHX9 determined 
using immunoluorescence microscopy. Quantiication of the number of cells with colocalised nucleolar CIZ1-
DHX9 showed reduced DHX9 nucleolar localisation with a concomitant reduction in CIZ1 nucleolar localisa-
tion (Fig. 4 A, B; Figure S5B). his suggests that DHX9 may facilitate recruitment of CIZ1 to the nucleolus. Next, 
to assess the whether DHX9 is required for CIZ1 nucleolar localisation, DHX9 siRNA were used to deplete 
DHX9 in asynchronous HeLa cells. his resulted in eicient depletion of DHX9 transcript (Fig. 4C) and pro-
tein levels (Fig. 4D; Figure S8). Monitoring the nucleolar CIZ1 levels in control siRNA and mock depleted cells 
showed ~ 60% of cells displayed colocalised nucleolar CIZ1 and DHX9 (Fig. 4E–H). his contrasts with DHX9 
depleted nuclei, where CIZ1 is mostly not detected in the nucleolus, with only ~ 8% of cells showing nucleolar 
CIZ1-DHX9 (Fig.  4E, H; Figure  S9). DHX9 depletion does not afect nucleolar localisation of B23 (Fig.  4F; 
Figure S10) and UBF (Fig. 4G) indicating a functional, intact nucleolus. hus, both siRNA mediated depletion 
of DHX9, and RNA polymerase I inhibition promotes nucleolar exclusion of DHX9 and CIZ1. Taken together 
these data suggest that DHX9 is required for CIZ1 nucleolar recruitment to maintain eicient cell cycle progres-
sion.
Discussion
his work has identiied a non-biased interaction network for CIZ1 using synchronised S-phase nucleosolic 
proteins. CIZ1 associates with DEAD/H Box helicases, splicing factors, regulators of ribosomal function, known 
XIST interactors and ribonucleoprotein complexes. he CIZ1 interactor proteins identiied here show a signii-
cant enrichment of nucleolar factors for both CIZ1 and CIZ1-RD (Table S5; FDR = 4.2e−12), consistent with the 
cell cycle regulated nucleolar location that we observe in early to mid S-phase HeLa cells. However, our analysis 
did not recover cyclin subunits, which are known to interact with CIZ1 and are required for its DNA replication 
activity. We demonstrated previously that the cyclin A-CIZ1 interaction is sensitive to CDK-mediated phospho-
rylation at three sites (T144, T192, T293), which signiicantly weakens their  ainity8. his is most likely because 
the conditions used here utilised S-phase extracts with physiological ATP levels, which is known to reduce 
CIZ1-cyclin ainity in vitro due to CDK mediated phosphorylation of  CIZ15,8.
he most signiicant hit was DHX9, a RNA and DNA helicase that has been associated with activation of 
DNA replication  origins34, translational  eiciency45, RNA  interference46, viral  infection47, regulation of nucleolar 
heterochromatin formation during embryonic stem cell  diferentiation33 and interacts with XIST  RNA11,12. Vali-
dation of the CIZ1-DHX9 complex was performed in vitro and in vivo and identiied that DHX9 contributes to 
CIZ1 nucleolar localisation in S-phase. CIZ1 interacts with DHX9 in vitro and is localised to the nucleolus for 
approximately 4 h in early S-phase in HeLa cells. he nucleolus is a node for complex signalling networks that 
integrate cellular growth and protein synthesis by regulation of ribosome biogenesis. he localisation of DHX9 
to the nucleolus can be inhibited by actinomycin  D48 (Fig. 4A, D) and siRNA mediated depletion (Fig. 4C, G, 
H). Importantly both approaches prevent nucleolar recruitment of CIZ1, suggesting that DHX9 is required 
for recruitment of CIZ1 to the nucleolus during this window. he depletion of DHX9 appeared to speciically 
afect CIZ1 nucleolar recruitment as nucleolar localisation of the RNA polymerase I transcription factor UBF, 
and Nucleophosmin were unafected by DHX9 depletion, consistent with normal nucleolar function in DHX9 
depleted cells (Fig. 4).
CIZ1 is proposed to contribute to regulation of transcriptional networks in cancer cell  lines14,49, regulation 
of DNA  replication5,6,8 and contributes to XIST binding to the inactive X  chromosome11,12. In each case, CIZ1 
may serve as a molecular scafold or recruitment factor to facilitate supramolecular assemblies. Of particular 
signiicance is recent observations that CIZ1 associates with XIST regulatory RNA at inactive X  chromosomes11,12. 
Further analysis of the CIZ1 interactors identiied here revealed 4 proteins (SRSF3, SRSF7, DDX5, and DDX17) 
that associate with  XIST32,  DHX950–52 and CIZ1 (Table 1). he identiication of common interactions from 
Figure 3.  CIZ1 colocalises with DHX9 in the nucleolus of cells normal ibroblasts and HeLa cells. (A) 
HeLa cells were imaged by immunoluorescence confocal microscopy. Upper panel: Total DNA is shown in 
blue; DHX9, green; CIZ1, Red and merged image. Middle panel: Total DNA shown in blue; DHX9, green; 
nucleophosmin (B23), Red and merged image. Lower panel: Total DNA shown in blue; UBF, green; CIZ1, 
Red and merged image. Yellow indicates colocalisation. White bar = 10 µm (B) As for A except human BJ 
ibroblasts were used. (C) Diferential interference contrast light microscopy showing puriied nucleoli. Black 
bar = 10 µm. (D) Western blot analysis of nucleoli from (C) for DHX9, CIZ1, nucleophosmin (B23) and actin. 
(E) Representative HeLa cell nuclei imaged by immunoluorescence confocal microscopy ater synchronisation 
in G1, S and G2 phase. Percentage of cells in S-phase in each population, as determined by BrdU incorporation, 
is shown. Total DNA is stained with DAPI (blue), CIZ1 (red) and DHX9 (green). White scale bar = 10 µm. (F) 
HeLa cells were synchronised in early S-phase with thymidine treatment and CIZ1 and DHX9 visualised by 
confocal luorescence microscopy. Representative images were taken as indicated ater removal of thymidine. 
Total DNA is shown in blue; DHX9, green; CIZ1, red and merged image, with yellow showing colocalisation. 
(G) Flow cytometry proiles of propidium iodide stained DNA in HeLa cells at indicated time points ater 
release from thymidine block. (H) Percentage of BrdU positive S-phase cells determined by pulse labelling at 
indicated time points ater release from thymidine block. Data shows mean ± SD, where 100 nuclei scored for 
each time point I) Percentage of nuclei showing nucleolar colocalisation for CIZ1/DHX9 at indicated time 
points. Data from three independent experiments showing mean ± SD, where > 50 nuclei scored for each time 
point.
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independent studies suggest that functional analysis of this is required to determine their potential roles in cell 
cycle regulation or XCI in future work.
he nucleolus is a highly dynamic structure that forms due to phase separation within the nucleus. he nucle-
olus integrates complex signals that integrate cellular growth, cell cycle phase and stress  responses53. In addition 
to its canonical functions of rDNA transcription, chromosome dynamics and gene silencing and allelic exclusion, 
there are emerging non-canonical roles. Our data show that both DHX9 and CIZ1 shuttle into the nucleolus in 
a cell cycle phase regulated process. Protein shuttling from the nucleus to the  nucleolus54,55 plays a key role in 
Figure 4.  CIZ1 localisation to the nucleolus requires DHX9. (A) Percentage of cells showing nucleolar 
localisation of CIZ1-DHX9 as determined by confocal microscopy. For triplicate experiments showing 
mean ± SD, where > 50 nuclei were scored for each time point. (B) Confocal immunoluorescence microscopy 
showing total DNA is shown in blue; DHX9, green; CIZ1, Red and merged image, with yellow showing 
colocalization, ± Actinomycin D. (C) Relative quantiication of DHX9 transcript levels for control and DHX9 
siRNA treated cells 24 h post-transfection. (D) Western blot analysis of DHX9 depleted cells showing levels of 
DHX9, CIZ1, nucleophosmin and actin protein. (E) Confocal luorescence microscopy of HeLa cells showing 
CIZ1/DHX9 ater control siRNA or DHX9 siRNA transfection. Total DNA is shown in blue; DHX9, green; 
CIZ1, Red and merged image, with yellow showing colocalisation. (F) Nucleolar localisation of nucleophosmin 
(B23) is independent of DHX9 expression. Total DNA is shown in blue; DHX9, green; nucleophosmin (B23), 
Red and merged image, with yellow showing colocalisation. (G) Nucleolar localisation of UBF is independent of 
DHX9 expression. Total DNA is shown in blue; UBF, green; CIZ1, red and merged image, with yellow showing 
colocalisation. (H) Percentage of cells showing nucleolar localisation of CIZ1-DHX9 as determined by confocal 
microscopy data shows mean ± SD, from 3 independent experiments each with > 50 nuclei scored.
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non-canonical nucleolar functions including telomere  maintenance56, RNA pol II mediated  transcription57, DNA 
 repair58,59 and  recombination60. Protein shuttling oten involves nucleolar proteins that act as scafolds for recruit-
ment and include nucleolin and nucleophosmin. Importantly, both nucleophosmin and nucleolin were found to 
associate with CIZ1 in this study (Fig. 1C) and DHX9 is known to interact with nucleolin (Fig. 1D). In addition, 
nucleolar recruitment is associated with disordered  structure61 and CIZ1 has a natively disordered N-terminal 
region that may contribute to its nucleolar shuttling. he data presented suggest that nucleolar CIZ1-DHX9 
localisation is required for eicient cell cycle progression and contribute to non-canonical roles in the nucleolus.
he nucleolar recruitment of factors can contribute to regulation of the cell  cycle56. he nucleolar recruit-
ment of CIZ1 and DHX9 may contribute to accurate replication of the ribosomal DNA (rDNA). Both  DHX934 
and  Ciz15,6,8 have been implicated in regulation of DNA replication via distinct mechanisms. rDNA represents a 
uniquely challenging template for DNA synthesis, which occurs at the nucleolar periphery during S-phase36 and 
requires temporospatial coordination with the transcriptional program. rDNA replication occurs in a bimodal 
program, with transcriptionally active regions replicating in early S-phase and inactive regions replicating in 
mid-late S-phase in NIH3T3  cells62. he perinucleolar region also appears to be a destination for the Xi chromo-
some in mid-late S-phase63, which engages in a CIZ1-dependent replication-linked transient visitation of the 
perinucleolar zone in normal primary mouse  ibroblasts13. While this takes place within a ~ 30 min window in 
primary murine ibroblasts, the accumulation of CIZ1-DHX9 to these regions in early S-phase in Hela and BJ 
ibroblasts suggest that these events are unrelated to XCI, as this process is maintained in male and female cell 
lines. he recruitment of CIZ1-DHX9 to the nucleolus is coordinated and regulated within the cell cycle, sug-
gesting that DHX9 and CIZ1 localisation to the nucleolus is required for eicient cell cycle progression. his is 
supported by observations that demonstrated that depletion of CIZ1 and DHX9 reduced cell cycle progression 
and S-phase  entry5,34. he common roles for CIZ1 and DHX9 in epigenetic regulation may provide a mechanism 
for diverse roles of Ciz1 and DHX9 play in many biological processes. he data presented here have identiied 
a network of proteins that are associated with nucleolar function and XCI. he data show Ciz1 interacts with 
DHX9 within the nucleolus for a short period of approximately 4 h at the beginning of S-phase. We propose that 
this transient nucleolar complex is required for eicient cell cycle progression, consistent with Ciz1 and DHX9 
contributing to integration of cell cycle regulation and nucleolar function during early S-phase.
Materials and methods
Cell culture┻ HeLa cervical carcinoma epithelial cells, BJ hTERT-immortalized human ibroblasts and 
NIH3T3 murine ibroblasts were cultured in D-MEM (Gibco) low glucose, glutamax I, 10% FCS, penicillin, 
streptomycin and glutamine at 37 °C, 5%  CO2/air in a humidiied incubator. Cells were passaged by trypsinisa-
tion at 60% conluency and split 1 in 2 or 1 in 3. For cell synchrony experiments, 3T3 cells were passaged and 
seeded at 30–40% conluence, media changed 24  h later and cultured for a further 48  h until conluent. At 
conluence fresh media was applied and cells cultured for a further 72 h before releasing into fresh medium at 
lower density (1 in 4 dilution) to stimulate re-entry into the cell cycle. S-phase cells were produced using a dou-
ble thymidine block, 24 h in 2.5 mM thymidine, released into fresh medium for 8 h before a second thymidine 
incubation for 16 h5,64. Cells were released into early S-phase by release into fresh medium for 1 h or 10 h for 
G2 cells, respectively. G2/M phase cells were produced by addition of 0.04 µg/ml nocodazole to S-phase cells for 
12 h prior to isolation. G1 cells were produced as for G2/M synchronized cells, ater which arrested cells were 
incubated for an additional 6 h in fresh media to complete mitosis and enter G1 phase. For immunoluorescence 
studies, cells were cultured on glass coverslips and synchronized as described above. To determine the number 
of cells in S-phase, EdU click it chemistry was used (Life Technologies) to label replicating nuclei. Percentage 
S-phase cells were determined by luorescence microscopy scoring nuclei with replication foci as positive.
Flow cytometry┻ Synchronised HeLa cells were produced by double thymidine treatment and released into 
fresh media. he cell cycle proile was determined by ixation overnight in 20% ethanol at − 20 °C and stained 
with 100 µg/ml propidium iodide in PBS, 0.5% v/v Triton X-100. Cell cycle proiles were determined using a BD 
FACScanto low cytometer, and FACSDiva sotware. Data was collected for 10,000 cells with consistent gating 
applied for all samples.
Nuclear extracts┻ Cells were washed in hypotonic bufer (10  mM HEPES, pH 7.8, 0.5  mM  MgCl2, 
5 mM K-acetate and 1 mM DTT), incubated in hypotonic bufer for 5 min and scrape harvested. Cell mem-
branes were disrupted by dounce homogenisation (Wheaton) and nuclei isolated ater centrifugation (10000 g, 
10 min) by removal of cytosolic proteins in supernatant. Nuclei were resuspended in hypotonic bufer, with the 
addition of 400 mM NaCl, and Complete EDTA free protease inhibitor cocktail (Roche). Nuclei were incubated 
for 5 min on ice and extracted proteins isolated by pelleting residual nuclei. he soluble fraction was used for 
binding studies with CIZ1 ater correction of the NaCl concentration to 135 mM by dilution in hypotonic bufer.
Protein expression and interaction studies┻ GST constructs were produced using the pGEX-6P3 vec-
tor containing full length ECIZ1, of derived fragments RD or N391 as  described5,8. E. coli BL21 (DE3) were used 
to overexpress each protein using autoinduction media and culturing at 20 °C for 24 h. Proteins were puriied as 
 described5. Ater extensive washing of GST-CIZ1 coated beads, S-phase salt extracts were applied, bound for 1 h 
at 4 °C and washed extensively with 50 mM HEPES, 135 mM NaCl, 10 mM  CaCl2, 20 mM  MgCl2, 0.1% Triton 
X-100, 1 mM DTT and complete protease inhibitor cocktail (Roche). For analysis by western blot, proteins were 
eluted by boiling beads in SDS-PAGE loading bufer for 10 min, followed by electrophoresis through 4–15% 
precast TGX gels, and transfer to nitrocellulose (GE). For analysis by mass spectrometry, binding partners were 
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eluted by overnight on-bead trypsinisation (Roche sequencing grade trypsin) diluted 1:50 in 100 mM sodium 
bicarbonate pH 8.0.
Mass spectrometry┻ Peptides mixtures were loaded onto a polystyrene-divinylbenzene polymeric mono-
lithic column (200 μm i.d. × 5 cm; LC Packings, NL) using an Ultimate nano-HPLC system (Dionex). Peptides 
were eluted at 3 μl/min low rate over a 20 min linear gradient of aqueous 3–50% (v/v) acetonitrile contain-
ing 0.1% (v/v) heptaluorobutyric acid. Fractions were collected every 6 s onto a MALDI target plate using a 
probot microfraction collector (Dionex), followed by post-column 0.9 μl/min addition of 6 mg/ml α-cyano-
4-hydroxycinnamic acid in aqueous 60% (v/v)  acetonitrile65. Positive-ion MALDI mass spectra were acquired 
using an Applied Biosystems 4700 Proteomics Analyzer (Applied Biosystems, Foster City, CA, USA) in relec-
tron mode. MS spectra were acquired over between m/z 800–4,000. Monoisotopic masses were obtained from 
centroids of raw, unsmoothed data. CID fragmentation was performed on the 20 strongest precursors with a 
signal to noise (S/N) greater than 50 for each LC fraction, with a fraction-to-fraction precursor exclusion of 
200 ppm applied. Collision energy of 1 kV was used, with air as the collision  gas66. he precursor mass window 
was set to a relative resolution of 50, and the metastable suppressor was enabled. he default calibration was 
used for  MS2 spectra, which were baseline-subtracted (peak width 50) and smoothed (Savitsky-Golay with three 
points across a peak and polynomial order 4); peak detection used a minimum S/N of 5, local noise window 
of 50 m/z, and minimum peak width of 2.9  bins66. Filters of S/N 20 and 30 were used for generating peak lists 
from MS and  MS2 spectra, respectively. Peak lists were submitted to a locally-running copy of the Mascot search 
program (Matrix Science Ltd., version 2.1) via the Applied Biosystems GPS Explorer sotware  interface65,66. Data 
were searched against the human subset of the NCBInr database. Search criteria speciied: Enzyme, trypsin; 
ixed modiications, Methythio (C); Variable modiications, Oxidation (M); Peptide tolerance, 100 ppm; MS/
MS tolerance, 0.1 Da; instrument, MALDI-TOF.TOF. Identiication signiicance was determined by GPS using a 
total Ion score C.I. % threshold of 99.5%, and a minimum of two peptide matches.
Antibodies for Western blotting and Immuno━uorescence┻ Rabbit polyclonal antibodies were pro-
duced previously for ECIZ1, (anti-Ciz1  17936), B23/nucleophosmin was purchased (sc-271737 Santa Cruz). 
Mouse monoclonal antibodies were used that recognise Actin (AC15), cyclin A (CY-1A) (Sigma Aldrich), UBF 
(sc-13125, Santa Cruz Biotech), DHX9 (sc-66997, Santa Cruz Biotech). Goat anti-rabbit peroxidase conjugates 
(Abcam), and goat anti-mouse peroxidase conjugates (Sigma Aldrich) were used with EtaC ECL Western blot-
ting chemiluminescence reagent (Genelow). Western blots were performed using 1% w/v BSA in TBS (Sigma 
Aldrich), 0.1% v/v Tween 20. For immunoluorescence, antibodies listed above were used at 1:100 dilution in 
PBS (Sigma Aldrich), 1% w/v BSA, 0.1% v/v, Triton X-100, 0.02% w/v SDS for 2 h at 37 °C, before extensive 
washing and labelling with luorescent secondary antibodies (1:2000) for 1 h at 37 °C using either Goat anti 
mouse-Alexa Fluor 488 and Goat anti-rabbit Alexa Fluor 568 (Life Technologies/hermoFisher). Cells were 
counter stained using DAPI- VectaShield to visualise nuclei.
Nucleoli puriボcation from Sば HeLa cells┻ Nucleolar puriication was performed as  described44, with 
minor modiications. Briely, 10 × 15 cm dishes of HeLa cells at 80% conluence were used for isolation of puri-
ied nucleoli. Cells were was washed and incubated in Bufer A (10 mM HEPES pH 7.9, 1.5 mM  MgCl2, 10 mM 
KCl, 0.5 mM DTT, 1 × Complete EDTA protease inhibitor tablet (Roche) for 5 min, scrape harvested and dounce 
homogenised. Nuclei were harvested by centrifugation at 228 × g for 5 min 4 °C. Nuclei were resuspended in S1 
bufer (0.25 M Sucrose, 10 mM  MgCl2) and layered over an equal volume of S2 (0.35 M Sucrose, 0.5 mM  MgCl2) 
and nuclei pelleted by centrifugation at 1430×g for 5 min 4 °C. Puriied nuclei were resuspended in bufer S2 
and sonicated. Nuclei were examined by Diferential interference contrast (DIC) microscopy and where intact 
nuclei were visible sonicated until nuclei had been efectively disrupted and nucleoli were visible. Nucleoli were 
isolated by layering the sonicated fraction over bufer S3 (0.88 M sucrose, 0.5 mM  MgCl2) and centrifugation 
at 2800×g for 5 min 4 °C. DIC microscopy was used to conirm presence of nucleoli and loss of nuclei prior to 
analysis by western blotting.
Immunoprecipitation reactions┻ HeLa cells were prepared and soluble nuclear extracts were prepared in 
binding bufer (50 mM HEPES pH 7.8, 10 mM  MgCl2, 20 mM  CaCl2 10 mM magnesium acetate, 0.04% NP40, 
2 × complete protease inhibitor cocktail (Roche), 10 mM ATP and 200 mM KCl). 2 μl of pre-immune rabbit sera 
or 2 μl of immunopuriied N471 antibody  (Covalabs8) were added as indicated for 2 h at 4 °C. Antibodies were 
immobilized on Immunopure protein A beads (Pierce Bioscience) for 1 h, washed ive times (10 × bead volume) 
in a binding bufer diluted 2:3 with distilled water, and analysed by western blot.
Transfection┻ Cells were transfected using Lonza nucleofection (Nucleofector 2C), program U-30 (NIH 
3T3), I-013 (HeLa) or X-001 (BJ cells), as recommended. Cells were then plated in fresh media and cultured, 
either on coverslips for 24 h for investigation by immunoluorescence, or on dishes for later scrape harvesting 
in PBS (Sigma Aldrich), 1 × complete protease inhibitor (Roche), 1 mM DTT for analysis by western blotting. 
Transfection of synchronised populations of 3T3 cells was performed on G0 populations prior to release into 
cycle, using half a conluent 15 cm dish per reaction, with 5 μM Silencer Select siRNA (hermoFisher). Silencer 
Negative Control No. 1 siRNA was used as a control transfection, with anti-DHX9 (siRNA ID: s4019, s4020 for 
HeLa and s231938 for mouse). 5 μM of each siRNA was used in 100 μL of Kit R transfection reagent (Lonza). 
Cells were plated into 3 × 9 cm plates for RNA extraction (PureLink RNA mini kit, hermoFisher), EdU label-
ling to determine S-phase population of cells (hermoFisher), and for protein extraction. Eiciency of transcript 
depletion was performed using quantitative real time PCR (qRT-PCR) using the ExPRESS superscript one-step 
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qPCR kit (Life Technologies) and Taqman probes (Life technologies: murine cell lines (3T3) control GAPDH 
(Mm03302249_m1), CIZ1 (Mm00503766_m1) or DHX9 Mm00456021_m1 (3T3). Human speciic Taqman 
probes Ciz1 (Hs00967155_m1) and DHX9 (Hs00357476_m1) and 18 s rRNA (Hs03003631_g1).
Imaging┻ Images were taken using a Zeiss LSM 510 or LSM880 laser scanning confocal microscope at a scan 
speed 6, average of 4 frames sequentially for each luorophore. Images were acquired with the pinhole set at 1 
Airy unit for each wavelength used. Imaging with Zeiss LSM510 used HFT dichroic mirror set UV/488/543/633 
used for excitation light and emission light collected with band pass (BP) 420–480 nm, BP 505–550 nm and 
long pass 560 nm. Imaging using a LSM880 used sequential imaging for minimal cross talk and collected light 
at 420–480 nm, 505–550 nm and 560–620 nm for DAPI, Alexa luor 488 and Alexa Fluor 568 emissions respec-
tively. Images were collected ater optimisation of dynamic range to ensure sub-saturation. Colocalisation was 
determined with Image J colocalisation sotware, Coloc2, using the Costes  method67. Images were cropped for 
presentation using Photoshop CS5.
Statistical analysis┻ Signiicant diferences in DNA replication activity were tested by one-way analysis 
of variance (ANOVA) followed by Tukey’s test post-hoc using IBM SPSS statistics 21. All signiicant results are 
shown in igures as appropriate where, **P < 0.01 and ***P < 0.001.
STRING analysis┻ Protein interaction partners were analysed using  STRING68 for CIZ1, ECIZ1-RD and 
shared CIZ1-DHX9 interaction partners. Functional interactions were produced and presented unaltered. Data 
uploaded to STRING will be made freely available on their website and local servers at Lancaster University.
URLs┻ String: https ://strin g-db.org
Biogrid: https ://thebi ogrid .org/
Coloc 2: https ://image j.net › Coloc_2.
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